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the aneurysm or false lumen, or both, in seven patients. Two had
a persistent perfusion of the false lumen at the level of the distal
segment of the stent graft, but the aneurysmal aortic segment at
risk of rupture was excluded and the diameter of the distal thoracic
aorta remained stable. One patient with a persisting type II endo-
leak has been recently treated successfully by direct Onyx injection
(Micro Therapeutics Inc, Irvine, Calif) in the aneurysmal sac. In
another patient, a type II endoleak resolved spontaneously, with
no change in aneurysm diameter. The remaining patient presented
with an asymptomatic retrograde dissection and persistent type II
endoleak. A Bentall procedure has been recently performed, with
a good result on the postoperative computed tomography scan.
Finally, at the end of this updated follow-up, the dissecting aneu-
rysm was excluded in all surviving patients.
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Regarding “Validation of three models predicting in-
hospital death in patients with an abdominal aortic
aneurysm eligible for both endovascular and open
repair”
We congratulate van Beek et al on their recently published
article that validates three risk prediction models for in-hospital
mortality following elective abdominal aortic aneurysm repair.1
Accurate risk prediction models are essential for informed consent,
clinical decision making, and risk-adjusting surgical outcome data.
Before using a risk prediction model in clinical practice, it is impor-
tant that it is robustly validated in any cohort of patients in which it
is to be used. Although two of the models assessed in the study
have previously been validated using registry data, the study by
van Beek et al represents the ﬁrst validation of all three models
using data from a randomized clinical trial.2
An interesting ﬁnding from the study is that the Vascular
Governance North West (VGNW) model outperformed the
British Aneurysm Repair (BAR) score with regard to discrimina-
tion, albeit marginally. This may be due to the fact that some
risk factor data were not available for calculation of the BAR
score.3 It may also be due to differences in the risk factors included
in the models with a history of respiratory disease and diabetes
included in the VGNW model but not in the BAR score.4
An important aspect of model performance is calibration.
Although the VGNW model and BAR score produce acceptable
Hosmer-Lemeshow test results, both models demonstrated a trend
toward underpredicting mortality in the Dutch Randomised
Endovascular Aneurysm Management (DREAM) trial cohort.
This is not surprising, as the DREAM trial was carried out from
2000 to 2003, the VGNW model was based on data from 1999
to 2009, and the BAR score was based on data from 2008 to
2011. As surgical standards and outcomes have improved overtime, it is inevitable that risk-prediction models such as the
VGNW and BAR models underpredict mortality in a historical
cohort. In turn, it is likely that risk models such as the BAR score
will tend to overpredict mortality in the future. This “calibration
drift” has been observed with cardiac surgery risk-prediction
models and means that regular model validations with recalibration
when necessary are vital.5 The combined outcome of in-hospital
and 30-day mortality used in the DREAM cohort is another
possible reason for the observed trend towards underprediction
of mortality by the VGNW and BAR scores.
We would encourage further validation studies of both the
VGNW and the BAR score and the use of both models in clinical
practice where appropriate. To facilitate easy calculation of the
BAR score, we have developed a web calculator, which is available
at www.britishaneurysmrepairscore.com, and an app is available
from both the Apple App Store and Google Play. A prospective
validation study of both the VGNW model and BAR score by
our group is currently underway.
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a complication of percutaneous vertebroplasty”
We have read with keen interest the paper by Mozaffar et al on
“Intra-arterial injection of acrylic cement as a complication of
percutaneous vertebroplasty.”1 The authors state that this is the
ﬁrst report of intra-arterial embolization of cement. In 2009,
however, we had published a case report of peripheral arterial
embolization of cement during revision spine surgery.2 Whereas
the case presented by Mozaffar et al differs in terms of the material
used (polymethylmethacrylate instead of bisphenol-a-glycidyl-
dimethacrylate-based cortical bone void ﬁller) and the type of
operation (percutaneous vertebroplasty instead of revision spine
surgery), the mechanism and the complication itself, from the
vascular surgery standpoint, is exactly the same (intra-arterial injec-
tion of cement with peripheral embolization).
An important conclusion that can be drawn from these two
papers is that Fogarty embolectomy from a proximal artery
(common femoral or popliteal artery) is fated to fail and that the
only possible bailout procedure is the exploration of the posterioror anterior tibial artery or even the dorsalis pedis or pedal arteries
for either removal of cement or a distal bypass.
In any case, these two case reports show that peripheral arterial
embolization of cement shouldnot be considered as an exotic compli-
cation but as a possibility that a vascular surgeon should be aware
of, given the increasing use of cement in orthopedic procedures.
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